RecruitingNot ApplicableNCT06937658

Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices


Sponsor

Beth Israel Deaconess Medical Center

Enrollment

120 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The Remote Alert Pathway to Optimize Care of Cardiac Implantable Electrical Devices (RAPTOR-CIED) Study is a pragmatic, multi-center, randomized trial with 1:1 patient-level randomization comparing the safety and effectiveness of alert-driven care versus guideline-based care for patients with wireless cardiac implantable electrical devices (CIEDs). The study will be conducted in 2 phases: a Feasibility Phase and a Main Phase. This registration outlines the goals and design features of the Feasibility Phase of the study.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Alert-based care and a medical device called Guideline-based care for people with implantable defibrillator user and pacemaker ddd. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAlert-based care

Alert-based care is an alternative strategy for longitudinal management of patients with wireless pacemakers and implantable defibrillators

DEVICEGuideline-based care

Guideline-based care is the current typical standard for longitudinal management of patients with wireless pacemakers and implantable defibrillators


Locations(1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06937658


Related Trials